Reactivity of FDA-approved anti-D reagents with partial D red blood cells

Immunohematology

Volumn 21, Issue 4, 2005, Pages 146-148

  Judd, W John ^a   Moulds, Marilyn ^b   Schlanser, Gloria ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b ImmucorGamma   (United States)

Author keywords

Anti D reagents; Gel column technology; Partial D red blood cells

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; REAGENT; RHESUS D ANTIBODY; RHESUS D ANTIGEN;

AGGLUTINATION TEST; ALLOIMMUNIZATION; ANALYTICAL EQUIPMENT; ARTICLE; BLOOD GROUP RH; BLOOD GROUP TYPING; BLOOD TRANSFUSION; COOMBS TEST; ERYTHROCYTE; FOOD AND DRUG ADMINISTRATION; IMMUNOREACTIVITY; PHENOTYPE; PRIORITY JOURNAL; PROPHYLAXIS;

BLOOD GROUPING AND CROSSMATCHING; ERYTHROCYTES; HUMANS; INDICATORS AND REAGENTS; ISOANTIBODIES; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 30844458989     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Flegel WA, Wagner FF. Molecular biology of partial D and weak D: implications for blood bank practice. Clin Lab 2002;45:53-9.
2. Marsh WL. Scoring of hemagglutination reactions. Transfusion 1972;12:352-3.
3. Reid ME, Lomas-Francis C. The blood group antigen factsbook. 2nd ed. San Diego, CA: Academic Press, 2004.
4. Fridey JL. Standards for blood banks and transfusion services. 22nd ed. Bethesda, MD: American Association of Blood Banks, 2003.
5. Garratty, G. Do we need to be more concerned about weak D antigens? Transfusion 2005;45:1547-51.